Evidence map›Paper›PMID 34616291›Full record

ArticleFrontiers in pharmacology2021

Antiradical and Cytoprotective Properties of

Shynggys Sergazy, Alexander Gulyayev, Aidana Amangeldiyeva, Ayaulym Nurgozhina, Madiyar Nurgaziyev, Zarina Shulgau, Laura Chulenbayeva, Zhanagul Khassenbekova, Almagul Kushugulova, Mohamad Aljofan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 7 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Shynggys SergazyNational Laboratory Astana, Nazarbayev University, Nur-Sultan, Kazakhstan.
Alexander GulyayevNational Laboratory Astana, Nazarbayev University, Nur-Sultan, Kazakhstan.
Aidana AmangeldiyevaKazakhstan Association of Researchers of the Human Microbiome, Nur-Sultan, Kazakhstan.
Ayaulym NurgozhinaNational Laboratory Astana, Nazarbayev University, Nur-Sultan, Kazakhstan.
Madiyar NurgaziyevNational Laboratory Astana, Nazarbayev University, Nur-Sultan, Kazakhstan.
Zarina ShulgauNational Center for Biotechnology, Nur-Sultan, Kazakhstan.
Laura ChulenbayevaNational Laboratory Astana, Nazarbayev University, Nur-Sultan, Kazakhstan.
Zhanagul KhassenbekovaNational Center for Biotechnology, Nur-Sultan, Kazakhstan.
Almagul KushugulovaNational Laboratory Astana, Nazarbayev University, Nur-Sultan, Kazakhstan.
Mohamad AljofanSchool of Medicine, Department of Biomedical Sciences, Nazarbayaev University, Nur-Sultan, Kazakhstan.
Nazarbayev University · KZNational Center for Biotechnology · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study is determine the

Indexed as

anti-radical activitiesCCl4-induced liver damagecytotoxicitydoxorubicinflavonoidpolyphenol

Identifiers

PMID34616291
PMCPMC8488157
OpenAlexW3198984075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.